NCT00542139View on ClinicalTrials.gov

Evaluation of Diprospan Injection to the Knee on Rehabilitation of Patients After TKR of the Contralateral Knee

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Osteoarthritis

Interventions

DRUG

Betamethasone

Intraarticular injection of 2ml Diprospan (wich contains 4mg Betamethasone sodium phosphate and 10mg Betamethasone dipropionate)

DRUG

Bupivocaine

Intraarticular injection of 10ml of Bupivocaine

Trial Locations (1)

Unknown

Hadassah Medical Organization, Jerusalem

All Listed Sponsors

lead

Hadassah Medical Organization

OTHER

NCT00542139 - Evaluation of Diprospan Injection to the Knee on Rehabilitation of Patients After TKR of the Contralateral Knee | Biotech Hunter | Biotech Hunter